Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy

Time-dependent change of relative apical longitudinal strain index in patients with wild-type transthyretin amyloid cardiomyopathy

Aim: This study was conducted to investigate the meaning of left ventricular (LV) apical sparing in patients with wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM). Methods and results: 165 patients who were diagnosed with ATTRwt-CM at Kumamoto University Hospital from January 2002 to Decem...

Full description

Bibliographic Details
Main Authors:	Hiroki Usuku, Eiichiro Yamamoto, Daisuke Sueta, Momoko Noguchi, Tomohiro Fujisaki, Koichi Egashira, Mami Morioka, Takashi Komorita, Fumi Oike, Koichiro Fujisue, Shinsuke Hanatani, Yuichiro Arima, Seiji Takashio, Seitaro Oda, Hiroaki Kawano, Kenichi Matsushita, Mitsuharu Ueda, Hirotaka Matsui, Kenichi Tsujita
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	Wild-type transthyretin amyloid cardiomyopathy Echocardiography Two-dimensional speckle tracking echocardiography Longitudinal strain Left ventricular apical sparing
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906722001956

Similar Items

Prognostic value of left atrial strain in patients with wild‐type transthyretin amyloid cardiomyopathy
by: Fumi Oike, et al.
Published: (2021-12-01)

Usefulness of automatic assessment for longitudinal strain to diagnose wild-type transthyretin amyloid cardiomyopathy
by: Hiroki Usuku, et al.
Published: (2023-08-01)

Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild‐type transthyretin amyloid cardiomyopathy
by: Seiji Takashio, et al.
Published: (2023-08-01)

Correlation Between Cardiac Images, Biomarkers, and Amyloid Load in Wild‐Type Transthyretin Amyloid Cardiomyopathy
by: Mami Morioka, et al.
Published: (2022-06-01)

Hereditary Transthyretin Amyloidosis: How to Differentiate Carriers and Patients Using Speckle-Tracking Echocardiography
by: Daniela Di Lisi, et al.
Published: (2023-12-01)

Identification of wild‐type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS)
by: Bertil Ladefoged, et al.
Published: (2023-02-01)

Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
by: Koichi Egashira, et al.
Published: (2022-06-01)

The usefulness of C-reactive protein to predict improving left ventricular function after aortic valve replacement in patients with aortic regurgitation
by: Hiroki Usuku, et al.
Published: (2022-05-01)

Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism
by: Jin-Beom Si, et al.
Published: (2021-04-01)

Urinary Transthyretin as a Biomarker in ATTRv Val50Met Amyloidosis
by: Hiroaki Matsushita, et al.
Published: (2022-06-01)

Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges
by: Sweety Sharma, et al.
Published: (2021-01-01)

The Interpretation and Update of the Diagnosis Pathway of Chinese Expert Consensus on the Diagnosis and Treatment of Transthyretin Cardiac Amyoidosis
by: TIAN Zhuang, et al.
Published: (2023-01-01)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
by: Huizhen Zou, et al.
Published: (2023-09-01)

Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
by: Vélez-Santamaría V, et al.
Published: (2022-12-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
by: Mariana Gospodinova, et al.
Published: (2020-07-01)

Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy
by: Paolo Morfino, et al.
Published: (2023-04-01)

British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis
by: William E. Moody, et al.
Published: (2023-08-01)

Transthyretin amyloid cardiomyopathy. Features of histological diagnosis: study design
by: Valeriia V. Guselnikova, et al.
Published: (2022-05-01)

Posttranslational Modifications of Transthyretin Are Serum Markers in Patients with Mycosis Fungoides
by: Niko Escher, et al.
Published: (2007-03-01)

Advanced approaches in echocardiography /
by: Gillam, Linda, et al.
Published: (c201)

Echocardiography board review : 400 multiple choice questions with discussion /
by: 304354 Pai, Ramdas, et al.
Published: (2007)

The yeast molecular chaperone, Hsp104, influences transthyretin aggregate formation
by: Adam S. Knier, et al.
Published: (2022-12-01)

Case Report: Hereditary transthyretin (ATTRv) amyloidosis: The p.G103R mutation of the transthyretin gene in a Han Chinese family is associated with vitreous hemorrhage
by: Junhui Shen, et al.
Published: (2022-09-01)

Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
by: Faruk Uğur Doğan, et al.
Published: (2019-03-01)

NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE
by: A. Ya. Gudkova, et al.
Published: (2018-03-01)

Human interface device for transesophageal remote manipulator /
by: Indhika Fauzhan Warsito, 1994-, author, et al.
Published: (2019)

Human interface device for transesophageal remote manipulator /
by: Indhika Fauzhan Warsito, 1994-, author 624336, et al.
Published: (2019)

Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer
by: Ellen Y. Cotrina, et al.
Published: (2020-09-01)

The ventilatory component of the muscle metaboreflex is overstimulated in transthyretin cardiac amyloidosis patients with poor aerobic capacity
by: Astrid Monfort, et al.
Published: (2023-05-01)

Wild-type Transthyretin Amyloid Deposition in an Ascending Aortic Aneurysm
by: Abbas Hoteit, MD, et al.
Published: (2024-05-01)

Transthyretin-Related Familial Amyloid Polyneuropathy: In the Light of New Developments
by: Arman Çakar, et al.
Published: (2017-09-01)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
by: Marianna Fontana, et al.
Published: (2023-11-01)

Decabromodiphenyl ethane induces locomotion neurotoxicity and potential Alzheimer’s disease risks through intensifying amyloid-beta deposition by inhibiting transthyretin/transthyretin-like proteins
by: Chen Wang, et al.
Published: (2022-10-01)

Lack of Association Between Neurohormonal Blockade and Survival in Transthyretin Cardiac Amyloidosis
by: Richard K. Cheng, et al.
Published: (2021-12-01)

Early life stressful experiences escalate aggressive behavior in adulthood via changes in transthyretin expression and function
by: Rohit Singh Rawat, et al.
Published: (2022-10-01)

Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy
by: Falcão de Campos C, et al.
Published: (2023-02-01)

Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
by: Juan González-Moreno, et al.
Published: (2023-12-01)

Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review
by: Ana-Maria Merino-Merino, et al.
Published: (2023-12-01)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
by: Francesco Bemporad, et al.
Published: (2022-02-01)

Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis
by: Dixon S, et al.
Published: (2023-11-01)